mRNA-Based Therapy in Melanoma, Personalized Neoantigen Vaccines and the Future of Precision Immunotherapy
Melanoma is one of the most immunogenic solid malignancies and has become a major model for the development of precision immunotherapy. Although immune checkpoint inhibitors and molecularly targeted therapies have substantially improved outcomes, primary and acquired resistance, disease recurrence and metastatic progre...